Discover 867 paid clinical trials in El Paso, Texas. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
El Paso offers a variety of clinical research opportunities focused on conditions such as asthma, diabetes, arthritis, and Parkinson’s disease. The city’s growing healthcare sector is actively recruiting participants, providing access to cutting-edge treatments for both healthy volunteers seeking paid research studies and individuals looking for trials targeting specific health conditions.
Filter
2
Filter results
Results: 867
A Study of Amivantamab and mFOLFOX6 or FOLFIRI Versus Cetuximab and mFOLFOX6 or FOLFIRI as First-line Treatment in Participants With KRAS/NRAS and BRAF Wild-type Unresectable or Metastatic Left-sided Colorectal Cancer
Location: Denver CO, Salt Lake City UT, Oklahoma City OK,
Sponsor: Artios Pharma Ltd
Sex: All
Age: 18+
Code: NCT04657068
Phase1, Phase2, Recruiting
Outpatient Administration of Teclistamab or Talquetamab for Multiple Myeloma
for
Multiple Myeloma
Location: Denver CO, Tucson AZ, Minneapolis MN, Tyler TX,
Sponsor: SCRI Development Innovations, LLC
Sex: All
Age: 18+
Code: NCT05972135
Phase2, Recruiting
A Study Comparing the Efficacy and Safety of Zanidatamab to Trastuzumab, Each in Combination With Physician's Choice Chemotherapy, for the Treatment of Participants With Metastatic HER2-positive Breast Cancer
for
Metastatic HER2-positive Breast Cancer
Location: Denver CO, Aurora CO, Kansas City MO, Phoenix AZ,
Sponsor: Jazz Pharmaceuticals
Sex: All
Age: 18+
Code: NCT06435429
Phase3, Recruiting
Clinical Study To Further Evaluate The Efficacy Of Dabrafenib Plus Trametinib In Patients With Rare BRAF V600E Mutation-Positive Unresectable or Metastatic Solid Tumors
for
Rare Unresectable or Metastatic BRAF V600E Mutation-positive Solid Tumors,
Location: Denver CO, El Paso TX, San Antonio TX, Torrance CA,
Sponsor: Novartis Pharmaceuticals
Sex: All
Age: 1 - 70+
Code: NCT05868629
Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
A Study of Amivantamab and FOLFIRI Versus Cetuximab/Bevacizumab and FOLFIRI in Participants With KRAS/NRAS and BRAF Wild-type Colorectal Cancer Who Have Previously Received Chemotherapy
Phase 2/3 Trial of Izalontamab Brengitecan vs Platinum-based Chemotherapy for Metastatic Urothelial Cancer With Disease Progression on or After Immunotherapy
for
Urothelial Cancer
Location: Denver CO, Edwards CO, Murray UT, St. George UT,
Sponsor: Bristol-Myers Squibb
Sex: All
Age: 18+
Code: NCT07106762
Phase2, Phase3, Recruiting
A Study of Xaluritamig Plus Abiraterone Versus Investigator's Choice in Participants With Chemotherapy-naïve Metastatic Castration-resistant Prostate Cancer
for
Metastatic Castration-resistant Prostate Cancer
Location: Denver CO, Oklahoma City OK, Westwood KS, Goodyear AZ,
Sponsor: Amgen
Sex: Male
Age: 18+
Code: NCT07213674
Phase3, Recruiting
Study Comparing AAA817+ARPI Versus Standard of Care in Adult Participants With PSMA-positive mCRPC
for
Prostate Cancer
Location: Denver CO, Albuquerque NM, Omaha NE, Kansas City KS,
Sponsor: Novartis Pharmaceuticals
Sex: Male
Age: 18 - 70+
Code: NCT06855277
Phase3, Recruiting
A Phase 2 Neoadjuvant Study of Zanidatamab in Combination With Chemotherapy in Participants With HER2-positive Breast Cancer
for
HER2-positive Breast Cancer, Breast Cancer
Location: Denver CO, Albuquerque NM, Lincoln NE, Omaha NE,
Sponsor: Jazz Pharmaceuticals
Sex: All
Age: 18+
Code: NCT07102381
Phase2, Recruiting
A Study of Izalontamab Brengitecan Versus Chemotherapy in Participants With Previously Untreated, Locally Advanced, Recurrent Inoperable, or Metastatic Triple-negative Breast Cancer Ineligible for Anti-PD(L)1 Drugs (IZABRIGHT-Breast01)
for
Breast Neoplasms
Location: Denver CO, El Paso TX, Kansas City MO, Flower Mound TX,
Sponsor: Bristol-Myers Squibb
Sex: All
Age: 18+
Code: NCT06926868
Phase2, Phase3, Recruiting
Study to Evaluate the Efficacy and Safety of [177Lu]Lu-DOTA-TATE in Patients With Grade 1 and Grade 2 Advanced GEP-NET
for
Somatostatin Receptor Positive (SSTR+),
Location: Denver CO, Scottsdale AZ, Fayetteville AR, Dallas TX,
Sponsor: Novartis Pharmaceuticals
Sex: All
Age: 12 - 70+
Code: NCT06784752
Phase3, Recruiting
A Study to Learn About the Study Medicine Called PF-08046054/SGN-PDL1V Versus Docetaxel in Adult Participants With Previously-Treated Programmed Cell Death Ligand 1 (PD-L1) Positive Non-Small-Cell Lung Cancer (NSCLC)
for
Non-small Cell Carcinoma, Non-Small Cell Lung Cancer Metastatic,
Symbiotic-GU-08: A Study to Learn About the Medicine Called PF-08634404 Dosed Alone and in Combination With Other Anticancer Therapies in Adults With Locally Advanced or Metastatic Renal Cell Cancer